MENU
+Compare
HIND
Stock ticker: NASDAQ
AS OF
Oct 20, 04:57 PM (EDT)
Price
$5.48
Change
+$0.20 (+3.79%)
Capitalization
29.01M

HIND Vyome Holdings Inc Forecast, Technical & Fundamental Analysis

Vyome Holdings Inc is a clinical stage specialty pharmaceutical company working to treat immuno-inflammatory diseases including rare indications of unmet need with next-generation therapeutic solutions... Show more

HIND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for HIND with price predictions
Oct 17, 2025

HIND in downward trend: price dove below 50-day moving average on September 23, 2025

HIND moved below its 50-day moving average on September 23, 2025 date and that indicates a change from an upward trend to a downward trend. In of 33 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 15, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on HIND as a result. In of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 10-day moving average for HIND crossed bearishly below the 50-day moving average on September 26, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIND declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for HIND entered a downward trend on October 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for HIND just turned positive on October 15, 2025. Looking at past instances where HIND's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HIND advanced for three days, in of 165 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (23.430). P/E Ratio (0.000) is within average values for comparable stocks, (54.529). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.181). Dividend Yield (0.000) settles around the average of (0.036) among similar stocks. P/S Ratio (96.154) is also within normal values, averaging (350.392).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HIND’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIND’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
HIND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OGS82.080.92
+1.13%
ONE GAS
MNST70.220.06
+0.09%
Monster Beverage Corp
AFRI8.60-0.03
-0.35%
Forafric Global PLC
EBON4.48-0.15
-3.24%
Ebang International Holdings
CNL11.62-1.23
-9.57%
COLLECTIVE MINING LTD

HIND and Stocks

Correlation & Price change

A.I.dvisor tells us that HIND and CRVS have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HIND and CRVS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HIND
1D Price
Change %
HIND100%
+4.35%
CRVS - HIND
30%
Poorly correlated
-7.97%
ACET - HIND
20%
Poorly correlated
-4.81%
RNTX - HIND
4%
Poorly correlated
-4.69%
YDES - HIND
3%
Poorly correlated
+6.49%
LIMN - HIND
2%
Poorly correlated
-6.50%
More